HRSAs Patient Safety and Clinical Pharmacy Services Collaborative The 12th Annual 340B Coalition Con - PowerPoint PPT Presentation

1 / 61
About This Presentation
Title:

HRSAs Patient Safety and Clinical Pharmacy Services Collaborative The 12th Annual 340B Coalition Con

Description:

Aging population - polypharmacy. ADEs leading cause of death and injury IOM Report ... Polypharmacy. 9. HIV/AIDS. 10. Multiple chronic conditions. 15 ... – PowerPoint PPT presentation

Number of Views:113
Avg rating:3.0/5.0
Slides: 62
Provided by: pc75170
Category:

less

Transcript and Presenter's Notes

Title: HRSAs Patient Safety and Clinical Pharmacy Services Collaborative The 12th Annual 340B Coalition Con


1
HRSAs Patient Safety and Clinical Pharmacy
Services CollaborativeThe 12th Annual 340B
Coalition ConferenceJuly 15, 2008
  • Denise H. Geolot, Ph.D., R.N.
  • Director, Center for Quality
  • Department of Health and Human Services
    (HHS)
  • Health Resources and Services Administration
    (HRSA)
  • Collaborative Co-Director
  • Jimmy Mitchell, R.Ph., MPH, MS
  • Director, Office of Pharmacy Affairs
  • HHS, HRSA
  • Collaborative Co-Director

Rebecca Hines, MHS, HHC Director, Prevention and
Special Initiatives Office of Planning and
Evaluation HHS, HRSA Improvement
Co-Advisor Krista M. Scardina, Pharm.D. Program
Management Officer Office of Pharmacy
Affairs HHS, HRSA Improvement Co-Advisor
2
What is the Collaborative?
  • Improve health outcomes, increase clinical
    pharmacy services, and improve patient safety
  • Rapid improvement method
  • Leading practices come from the field

3
The Challenge
  • Increase in multiple chronic conditions
  • Aging population - polypharmacy
  • ADEs leading cause of death and injury IOM
    Report
  • Lack of integration of clinical pharmacy services

4
Institute of Medicine Findings on Patient Safety
and Errors
  • Medication Errors are Most Common
  • Injure 1.5 Million People Annually
  • Cost Billions Annually
  • for every dollar spent on ambulatory
    medications, another dollar is spent to treat new
    health problems caused by the medication.

5
Why a Patient Safety Clinical Pharmacy
Collaborative?
  • The Senate Appropriations Committee further
    encourages HRSA to establish a pharmacy
    collaborative to identify and implement best
    practices, which may improve patient care by
    establishing the pharmacist as an integral part
    of a patient-centered, interprofessional health
    care team.
  • 2007 2008 Senate Appropriations Committee
    Reports Encourage Pharmacy Collaborative.

6
HRSAs Commitment
  • Support programs to provide the best and safest
    care in the Nation
  • Take previously supported Collaboratives with
    documented improvements to the next level

7
HRSA Pharmacy Programs
  • Pharmacy services are growing rapidly

1999
8,000 entities
2008
13,000 entities
5 Billion
8

PSPC Goals
  • Improve Health Outcomes
  • Improve Patient Safety
  • Increase High Quality, Cost-Effective Pharmacy
    Services

9
Patient Safety Pharmacy Collaborative
Patient Safety
Clinical Pharmacy Services
QUALITY
Health Outcomes
10
Patient Safety Pharmacy Collaborative
Patient
Optimum Health Outcomes
Integrated Patient Care
Clinical Pharmacy Services
No Adverse Events
11
Evolving into the Future
  • Were ready to go beyond improvements one disease
    at a time!
  • Evidence that system improvements in pharmacy
    will improve overall outcomes for patients
  • Target high risk patients across a broad range of
    chronic conditions

12
Milestones Weve Come a Long Way FastSpring
2007 Summer 2008
  • Study Phase
  • Identified High Performers
  • Conducted 34 site visits
  • Compiled Leading Practices
  • Convened Expert Panel
  • Engaged Partners
  • Leadership Coordinating Council
  • Sponsored State Leadership Meeting
  • Implementation Phase
  • Enrolled Teams
  • Faculty Selected

13
Support for Collaborative
  • HRSA Leadership, Bureaus and Offices
  • National Faculty and HRSA Team
  • Leadership Coordinating Council of National
    Partner Organizations
  • State-Based Organizations

14
Who are some of Our National Partners?
  • Apexus/Prime Vendor Program NASTAD
  • and many others

15
Study Phase
  • What are the leading practices?
  • Where do they come from?

16
Site Selection Criteria
  • Primary criteria
  • Clinical outcomes data - EVIDENCE
  • Data demonstrating effectiveness of their patient
    safety and pharmacy services
  • Innovative patient safety and pharmacy services
    models
  • Implemented in outpatient primary care settings
  • Secondary criteria
  • Regions which had clusters of 34 organizations
    that met the above criteria
  • Regional representation

17
Site Visits
  • 34 Sites included in the sample
  • Site visits with 30 high-performing organizations
    in 7 regions of the country
  • Telephone visit with 4 organizations in
    additional regions

18
(No Transcript)
19
Example High-Performer Outcomes
20
Organization Types
21
Characteristics of Participating Organizations
22
Site Observations
23
High Performer
  • Joshua Feldmann, RPh, PharmD
  • Mercy Family Pharmacy

24
  • How did we capture the leading practices
  • from the sites?

25
Key Framing Questions for the Study Phase
  • What are the successful practices that high
    performing providers are using?
  • What do they look like in practice?
  • Who can articulate and project these practices
    with clarity and power?

26
The Change Package
  • Menu of Promising Action Items for Testing and
    Adapting for Use by Teams in Their Home Settings

27
Whats In a Change Package?
  • Strategies
  • Plans for Achieving an End System-Wide
    Improvement
  • Change Concepts
  • Approaches Found to Be Useful in Developing
    Specific Ideas for Changes That Lead to an
    Improvement
  • Action Steps
  • Specific Ideas to Implement Each Change Concept

28
What Forms the Basis for the Change Package?
  • Existing Research Literature
  • Leading Practices of High Performers
  • Expert Panel
  • Experiences of Collaborative Teams

29
Data Analysis
  • Qualitative data analysis software
  • Themes and strategies coded using inductive
    analysis techniques
  • Change Package content updated iteratively
  • Nine versions of the Change Package presented by
    the study team
  • Each version increased in specificity and clarity

30
Strategies What Weve Learned
  • Leadership Commitment
  • Develop organizational relationships that
    promote safe medication-use systems and optimal
    health outcomes
  • Measurable Improvement
  • Achieve change using the value and power of
    data- driven improvements
  • Integrated Care Delivery
  • Build an integrated health care system across
    providers and settings that produces safety and
    optimal health outcomes
  • Safe Medication Use Systems
  • Develop and operate by safe medication-use
    practices
  • Patient-Centered Care
  • Build a patient-centered medication-use system

31
Strategy
Safe Medication Use Systems
Change Concept
Systematically introduce and institutionalize
safe medication-use practices and monitoring
procedures
Action Items
  • Require double-checking when pharmacist is
    unavailable, e.g., develop and utilize policies
    requiring two nurses to verify the right drug
    when nurses access medication storage.
  • Do not use medication abbreviations or verbal
    orders.
  • Facilitate patient access to prescriptions by
    using strategies that ensure RX pick-up, e.g,
    home delivery, mail service, dispensing window,
    partnership with community pharmacy.

32
The Work of the Collaborative
  • Create Expectation That Each Team Begins by
    Addressing a Change Concept Under Each Strategy
  • Use the Improvement Model (Plan/Do/Study/Act) to
    test specific actions in their environment

33
Implementation Phase
  • Q How do we spread these leading practices?
  • A TEAMS
  • with support from FACULTY

34
Who Are the Faculty?
  • Majority are from leading practice sites from
    study phase
  • Mix of leaders, physicians, pharmacists, nurses,
    and others
  • Innovators and early adapters
  • Voice of the Change Package
  • Peer leaders to inspire change by showing the way

35
Who Are the Teams?
  • Teams of providers
  • Multiple organizations within communities
  • Defined patient population

36
Team Participants
  • 91 teams
  • Over 300 organizations
  • Teams average 3 organizations
  • Over 500 participants will participate in the
    Learning Sessions

37
Team Participants
  • 42 states represented (including HI and PR)
  • 7 teams from Massachusetts
  • 5 each
  • Ohio
  • New Jersey
  • Louisiana
  • All geographic areas represented

38
Participating Teams
Hawaii
Puerto Rico
39
Team Examples Target Populations
40
Team Configuration Examples
  • CHC Disproportionate Share Hospital Rural
    Health Clinic Community Pharmacy
  • HIV Clinic Critical Access Hospital Womens
    Health Clinic
  • Multiple CHCs Disproportionate Share Hospital
    and their associated clinics
  • Rural Health Clinic Hospital School/College
    of Pharmacy

41
Opportunity or Risk?
Hospital Inpatient
Patient Multiple Conditions
Hospital ED
Primary Care Home(s)
Specialist
42
Hospital In Patient
Patient Multiple Conditions
Hospital ED
Primary Care Home(s)
Pharmacy Services
Specialist
43
RISK
Hospital In Patient
Patient Multiple Conditions
Hospital ED
Conditions For A Disaster
Primary Care Home(s)
Pharmacy Services
Specialist
44
OPPORTUNITY
Patient
Hospital In Patient
Multiple Conditions
Hospital ED
Patient Self- Management
Primary Care Home(s)
Pharmacy Services
ClinicalPharmacy Services
Specialist
45
Teams Include
  • Clinical pharmacists
  • Nurses
  • Physicians
  • Other primary care clinicians
  • QI staff
  • Administrators
  • Senior Leaders
  • More!!

46
What Will Teams Do?
  • Commit to Collaborative aims
  • Commit time and effort
  • Designate consistent members to attend all 4
    Learning Sessions and support travel
  • Measure and track progress
  • Share activities and results
  • Align with team around continuity of care
  • Bring their organizations senior leader(s) to a
    designated Learning Session

47
Team Example
  • Tracey Cole, RPh
  • Pharmacy Director
  • Holyoke Health Center

48
How Does the PSPC Create Improvements?
  • 16 month rapid learning model
  • Focused on improving health outcomes
  • Led by an expert faculty and national leaders
  • Creates community of learning
  • Learning Sessions and Action Periods are venues
    for change
  • Improvements are tracked and shared for mutual
    benefit

49
Learning Collaborative Process
Enroll Participants
Select Topic
Prework
Identify Change Concepts
P
P
P
D
A
A
D
A
D
S
S
S
Planning Group
LS 1
LS 2
AP1
AP2
AP3
LS 3
LS 4
LS 4
Supports Listserv Site Visits
Filming Conference Calls Rapid
Sharing Team Reporting Web
site Leadership Coordinating Council
PDSAPlan, Do, Study, Act LS Learning
Session APAction Period
Adapted from IHI Breakthrough Series
Collaboratives IHI.org
50
PDSA Rapid Improvement Technique
Rapid Testing!!
Plan
Do
Act
Study
By Tuesday we will
51
Repeated Use of the PDSA Cycle
Changes That Result in Improvement
Where we want to end up
52
Repeated Use of the PDSA Cycle
Changes That Result in Improvement
Where we want to end up
Hunches Theories Ideas
Where we start
53
Repeated Use of the PDSA Cycle
Changes That Result in Improvement
DATA
We build a bridge with data and action.
Hunches Theories Ideas
54
Repeated Use of the PDSA Cycle
Changes That Result in Improvement
DATA
Implementation of Change
Wide-Scale Tests of Change
Follow-up Tests
Hunches Theories Ideas
Very Small Scale Test
55
Repeated Use of the PDSA Cycle
Changes That Result in Improvement
Rapid Testing!!
DATA
Implementation of Change
Wide-Scale Tests of Change
Follow-up Tests
Hunches Theories Ideas
By Tuesday we will
Very Small Scale Test
56
Key Benefits of Team Participation in the PSPC
  • Its the Right Thing to Do for the Patients We
    Serve
  • Safer
  • More and improved Clinical Pharmacy Services
  • Improved Health Outcomes
  • Reduces and Manages Risk
  • Builds on and Takes Prior Experience to a New
    Level
  • Works across organizations in a community
  • Goes beyond improvements in one disease state

57
Key Benefits of Team Participation in the PSPC
  • Gain expertise in creating linkages and
    partnerships across organizations using
    patient-centered approach
  • Exposure to Cutting Edge People and Methods on
    Quality Improvement, Leadership Change
    Management
  • Chance to Be A Part of a Major National Movement
    in a Rewarding All Teach, All Learn Environment
  • Access to expert faculty and technical assistance
    to develop and test high leverage changes

58
The Work of the Collaborative
  • Teams are Major Locus of Change
  • Change Package is Recipe Book for Change
  • Strategies Change Concepts Action Items
  • Plan Do Study Act cycles for creating
    change
  • Introduced and Led by a Faculty of Their Peers
  • Drawn from the field
  • Articulate leading practices that get results

59
What to Remember..
  • Improve health outcomes, increase clinical
    pharmacy services, and improve patient safety
  • Rapid Improvement Approach
  • Leading practices from field

60
Timeline
  • July 2008 Faculty Meeting
  • August 2008 Learning Session 1
  • Fall 2008 Action Period 1
  • December 2008 Learning Session 2
  • Winter 2008-09 Action Period 2
  • Spring 2009 Learning Session 3
  • Summer 2009 Action Period 3
  • Fall 2009 Learning Session 4
  • Improved Patient Outcomes!

61
PSPC Information
  • HRSA Website
  • www.hrsa.gov/patientsafety
  • Questions?
  • patientsafety_at_hrsa.gov
  • HRSA Knowledge Management System
  • www.healthdisparities.net
Write a Comment
User Comments (0)
About PowerShow.com